|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | National Institute of Environmental Health Sciences (NIEHS) |
|---|---|
| Information provided by: | National Institute of Environmental Health Sciences (NIEHS) |
| ClinicalTrials.gov Identifier: | NCT00042705 |
Purpose
This study measures residential exposures (indoor allergens, mold, nitrogen dioxide, nicotine) and relates exposure levels to daily symptoms (wheeze, persistent cough, chest tightness, shortness of breath) and medication use, in a population of children with physician diagnosed asthma, followed for 12 months.
| Condition |
|---|
|
Asthma |
| Study Type: | Observational |
| Study Design: | Observational Model: Defined Population Observational Model: Natural History Time Perspective: Longitudinal Time Perspective: Prospective |
Eligibility| Ages Eligible for Study: | 5 Years to 11 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Contacts and Locations| United States, Connecticut | |
| Yale Center for Perinatal, Pediatric & Environmental Epidemiology | Recruiting |
| New Haven, Connecticut, United States, 06510 | |
| Contact: Kathleen Belanger, PhD 203-764-9375 kathleen.belanger | |
| Principal Investigator: Brian Leaderer, PhD | |
More Information
| ClinicalTrials.gov Identifier: | NCT00042705 History of Changes |
| Other Study ID Numbers: | 5410-CP-001 |
| Study First Received: | August 5, 2002 |
| Last Updated: | June 23, 2005 |
| Health Authority: | United States: Federal Government |
|
asthma indoor allergens |
|
Asthma Bronchial Diseases Respiratory Tract Diseases Lung Diseases, Obstructive Lung Diseases |
Respiratory Hypersensitivity Hypersensitivity, Immediate Hypersensitivity Immune System Diseases |